精神疾病神经调控疗法决策框架
A decision-making framework for neuromodulation modalities in psychiatric disorders
该综述提出针对抑郁症、强迫症、PTSD等精神障碍的神经调控疗法决策框架,系统汇总重复经颅磁刺激、深部脑刺激、迷走神经刺激、电休克治疗及聚焦超声等证据等级与适用场景,供临床选择参考。
Siddiqi, S. H., Kording, K. P., Parvizi, J. & Fox, M. D. Causal mapping of human brain function. Nat. Rev. Neurosci. 23, 361–375 (2022).
Lisanby, S. H., Luber, B., Schlaepfer, T. E. & Sackeim, H. A. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 28, 1852–1865 (2003).
Deng, Z.-D. et al. Clinical outcomes of magnetic seizure therapy vs electroconvulsive therapy for major depressive episode: a randomized clinical trial. JAMA Psychiatry 81, 240–249 (2024).
Dougherty, D. D. et al. Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive–compulsive disorder. Am. J. Psychiatry 159, 269–275 (2002).
Rasmussen, S. A. et al. Gamma ventral capsulotomy in intractable obsessive–compulsive disorder. Biol. Psychiatry 84, 355–364 (2018).
Davidson, B. et al. Magnetic resonance-guided focused ultrasound capsulotomy for refractory obsessive compulsive disorder and major depressive disorder: clinical and imaging results from two phase I trials. Mol. Psychiatry 25, 1946–1957 (2020).
McLaughlin, N. C. R. et al. Magnetic resonance imaging-guided laser thermal ventral capsulotomy for intractable obsessive–compulsive disorder. Neurosurgery 88, 1128–1135 (2021).
Nuttin, B., Cosyns, P., Demeulemeester, H., Gybels, J. & Meyerson, B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive–compulsive disorder. Lancet 354, 1526 (1999).
Mallet, L. et al. Subthalamic nucleus stimulation in severe obsessive–compulsive disorder. N. Engl. J. Med. 359, 2121–2134 (2008).
Mayberg, H. S. et al. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651–660 (2005).
Barker, A. T., Jalinous, R. & Freeston, I. L. Non-invasive magnetic stimulation of human motor cortex. Lancet 1, 1106–1107 (1985).
Blumberger, D. M. et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 391, 1683–1692 (2018).
Cole, E. J. et al. Stanford Neuromodulation Therapy (SNT): a double-blind randomized controlled trial. Am. J. Psychiatry 179, 132–141 (2022).
Cole, E. J. et al. Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression. Am. J. Psychiatry 177, 716–726 (2020).
Woodham, R. D. et al. Home-based transcranial direct current stimulation treatment for major depressive disorder: a fully remote phase 2 randomized sham-controlled trial. Nat. Med. 31, 87–95 (2025).
Fang, J. et al. Transcutaneous vagus nerve stimulation modulates default mode network in major depressive disorder. Biol. Psychiatry 79, 266–273 (2016).
Legon, W. et al. Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans. Nat. Neurosci. 17, 322–329 (2014).
Davidson, B. et al. A roadmap for focused ultrasound applications in psychiatry: proceedings of the 2024 symposium on focused ultrasound in psychiatry (FUS-PULSE). Brain Stimul. 18, 1651–1662 (2025).
Rakita, U., Bingham, K., Fung, K. & Giacobbe, P. Factors associated with global variability in electroconvulsive therapy utilization. J. ECT 33, 253–259 (2017).
Malhi, G. S. et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust. N. Z. J. Psychiatry 55, 7–117 (2021).
Lam, R. W. et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults: Réseau canadien pour les traitements de l’humeur et de l’anxiété (CANMAT) 2023: mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Can. J. Psychiatry 69, 641–687 (2024).
Depression in adults: treatment and management. National Institute for Health and Care Excellence https://www.nice.org.uk/guidance/ng222 (29 June 2022).
Van Ameringen, M. et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive−Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive–compulsive disorder. J. Psychiatr. Res. https://doi.org/10.1016/j.jpsychires.2025.12.039 (2026).
Obsessive–compulsive disorder and body dysmorphic disorder: treatment. National Institute for Health and Care Excellence https://www.nice.org.uk/guidance/cg31/resources/2019-surveillance-of-obsessivecompulsive-disorder-and-body-dysmorphic-disorder-treatment-nice-guideline-cg31-6713804845/chapter/Overview-of-2019-surveillance-methods?tab=evidence (29 November 2005).
Jelovac, A., Kolshus, E. & McLoughlin, D. M. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology 38, 2467–2474 (2013).
Kellner, C. H. et al. A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study. Am. J. Psychiatry 173, 1110–1118 (2016).
Nordenskjöld, A. et al. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial. J. ECT 29, 86–92 (2013).
Cavenaghi, V. B. et al. Magnetic seizure therapy for unipolar and bipolar depression: an up to date systematic review. World J. Biol. Psychiatry 26, 49–59 (2025).
Giacobbe, P. & Husain, M. I. Extending the impact of mood disorder care through treatment optimization and accessibility. Can. J. Psychiatry 70, 729–731 (2025).
Vida, R. G. et al. Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials. BMC Psychiatry 23, 545 (2023).
Trapp, N. T. et al. Consensus review and considerations on TMS to treat depression: a comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology. Clin. Neurophysiol. 170, 206–233 (2025).
Dalhuisen, I. et al. rTMS as a next step in antidepressant nonresponders: a randomized comparison with current antidepressant treatment approaches. Am. J. Psychiatry 181, 806–814 (2024).
Papakostas, G. I. et al. Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial. Mol. Psychiatry 29, 2287–2295 (2024).
Kishi, T. et al. Repetitive transcranial magnetic stimulation for bipolar depression: a systematic review and pairwise and network meta-analysis. Mol. Psychiatry 29, 39–42 (2024).
Senova, S., Cotovio, G., Pascual-Leone, A. & Oliveira-Maia, A. J. Durability of antidepressant response to repetitive transcranial magnetic stimulation: systematic review and meta-analysis. Brain Stimul. 12, 119–128 (2019).
Levkovitz, Y. et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry 14, 64–73 (2015).
Haesebaert, F., Moirand, R., Schott-Pethelaz, A.-M., Brunelin, J. & Poulet, E. Usefulness of repetitive transcranial magnetic stimulation as a maintenance treatment in patients with major depression. World J. Biol. Psychiatry 19, 74–78 (2018).
Noda, Y. et al. Repetitive transcranial magnetic stimulation as maintenance treatment of depression: the MAINT-R randomized clinical trial. JAMA Netw. Open 8, e2515881 (2025).
Moshfeghinia, R., Bordbar, S., Roointanpour, Y., Arab Bafrani, M. & Shalbafan, M. Efficacy and safety of home-based transcranial direct current stimulation (tDCS) on patients with depressive disorders: a systematic review and meta-analysis of randomized clinical trials. Sci. Rep. 15, 43850 (2025).
Carpenter, L. L., George, M. S., Navarro, N., Deutsch, L. & Leuchter, A. F. A novel home-based, combined occipital and trigeminal afferent stimulation therapy for major depressive disorder: efficacy and safety results from a double-blind multicenter randomized sham-controlled study. Brain Stimul. 18, 1695–1704 (2025).
Ren, C. et al. Transcranial electrical stimulation in treatment of depression: a systematic review and meta-analysis. JAMA Netw. Open 8, e2516459 (2025).
Brunoni, A. R. et al. Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data. Br. J. Psychiatry 208, 522–531 (2016).
Li, S. et al. Comparative effectiveness of transcutaneous auricular vagus nerve stimulation vs citalopram for major depressive disorder: a randomized trial. Neuromodulation 25, 450–460 (2022).
Fan, J. M. et al. Thalamic transcranial ultrasound stimulation in treatment resistant depression. Brain Stimul. 17, 1001–1004 (2024).
Riis, T. S. et al. Noninvasive modulation of the subcallosal cingulate and depression with focused ultrasonic waves. Biol. Psychiatry 97, 825–834 (2025).
Barksdale, B. R. et al. Low-intensity transcranial focused ultrasound amygdala neuromodulation: a double-blind sham-controlled target engagement study and unblinded single-arm clinical trial. Mol. Psychiatry 30, 4497–4511 (2025).
Attali, D. et al. Deep transcranial ultrasound stimulation using personalized acoustic metamaterials improves treatment-resistant depression in humans. Brain Stimul. 18, 1004–1014 (2025).
Carmi, L. et al. Efficacy and safety of deep transcranial magnetic stimulation for obsessive−compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. Am. J. Psychiatry 176, 931–938 (2019).
Kar, S. K., Agrawal, A., Silva-Dos-Santos, A., Gupta, Y. & Deng, Z.-D. The efficacy of transcranial magnetic stimulation in the treatment of obsessive−compulsive disorder: an umbrella review of meta-analyses. CNS Spectr. 29, 109–118 (2024).
Roth, Y. et al. Real-world efficacy of deep TMS for obsessive−compulsive disorder: post-marketing data collected from twenty-two clinical sites. J. Psychiatr. Res. 137, 667–672 (2021).
Rehn, S., Eslick, G. D. & Brakoulias, V. A meta-analysis of the effectiveness of different cortical targets used in repetitive transcranial magnetic stimulation (rTMS) for the treatment of obsessive−compulsive disorder (OCD). Psychiatr. Q. 89, 645–665 (2018).
Chou, T. et al. Transcranial focused ultrasound of the amygdala modulates fear network activation and connectivity. Brain Stimul. 17, 312–320 (2024).
Chandler, J. A. et al. International legal approaches to neurosurgery for psychiatric disorders. Front. Hum. Neurosci. 14, 588458 (2020).
Denys, D. et al. Efficacy of deep brain stimulation of the ventral anterior limb of the internal capsule for refractory obsessive−compulsive disorder: a clinical cohort of 70 patients. Am. J. Psychiatry 177, 265–271 (2020).
Rush, A. J. et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol. Psychiatry 58, 347–354 (2005).
Brown, L. T. et al. Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive−compulsive disorder: a systematic review of observational studies. J. Neurosurg. 124, 77–89 (2016).
Satzer, D., Mahavadi, A., Lacy, M., Grant, J. E. & Warnke, P. Interstitial laser anterior capsulotomy for obsessive−compulsive disorder: lesion size and tractography correlate with outcome. J. Neurol. Neurosurg. Psychiatry 93, 317–323 (2022).
Greenberg, B. D. et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive−compulsive disorder. Neuropsychopharmacology 31, 2384–2393 (2006).
Gupta, A. et al. An international radiosurgery research foundation multicenter retrospective study of gamma ventral capsulotomy for obsessive compulsive disorder. Neurosurgery 85, 808–816 (2019).
Hageman, S. B. et al. Deep brain stimulation versus ablative surgery for treatment-refractory obsessive−compulsive disorder: a meta-analysis. Acta Psychiatr. Scand. 143, 307–318 (2021).
Aaronson, S. T. et al. A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and suicidality. Am. J. Psychiatry 174, 640–648 (2017).
Conway, C. R. et al. Vagus nerve stimulation in treatment-resistant depression: a one-year, randomized, sham-controlled trial. Brain Stimul. 18, 676–689 (2025).
Nierenberg, A. A., Alpert, J. E., Gardner-Schuster, E. E., Seay, S. & Mischoulon, D. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol. Psychiatry 64, 455–460 (2008).
Dougherty, D. D. et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol. Psychiatry 78, 240–248 (2015).
Holtzheimer, P. E. et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. Lancet Psychiatry 4, 839–849 (2017).
Giacobbe, P. et al. Deep brain stimulation to the subgenual cingulate gyrus for treatment-resistant depression: a randomized controlled trial and 2-year long-term follow-up: Stimulation cérébrale profonde du gyrus cingulaire subgénual pour traiter la dépression résistante au traitement: essai contrôlé à répartition aléatoire et suivi à long terme sur deux ans. Can. J. Psychiatry 71, 266–276 (2026).
Puigdemont, D. et al. A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention. J. Psychiatry Neurosci. 40, 224–231 (2015).
Martínez-Álvarez, R. & Torres-Diaz, C. Modern gamma knife radiosurgery for management of psychiatric disorders. Prog. Brain Res. 270, 171–183 (2022).
Lopes, A. C. et al. Gamma ventral capsulotomy for obsessive−compulsive disorder: a randomized clinical trial. JAMA Psychiatry 71, 1066–1076 (2014).
Kumar, K. K. et al. Comparative effectiveness of neuroablation and deep brain stimulation for treatment-resistant obsessive−compulsive disorder: a meta-analytic study. J. Neurol. Neurosurg. Psychiatry 90, 469–473 (2019).
Lai, Y. et al. Effectiveness and safety of neuroablation for severe and treatment-resistant obsessive−compulsive disorder: a systematic review and meta-analysis. J. Psychiatry Neurosci. 45, 356–369 (2020).
Denys, D. et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive−compulsive disorder. Arch. Gen. Psychiatry 67, 1061–1068 (2010).
Greenberg, B. D. et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive−compulsive disorder: worldwide experience. Mol. Psychiatry 15, 64–79 (2010).
Gadot, R. et al. Efficacy of deep brain stimulation for treatment-resistant obsessive−compulsive disorder: systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 93, 1166–1173 (2022).
Miguel, E. C. et al. Evolution of gamma knife capsulotomy for intractable obsessive−compulsive disorder. Mol. Psychiatry 24, 218–240 (2019).
Baethge, C. Error in calculating main outcome in gamma ventral capsulotomy for obsessive−compulsive disorder randomized clinical trial. JAMA Psychiatry 72, 1257–1258 (2015).
Hamani, C. et al. Long-term safety and efficacy of focused ultrasound capsulotomy for obsessive−compulsive disorder and major depressive disorder. Biol. Psychiatry 97, 698–706 (2025).
Chang, K. W. et al. Long-term clinical outcome of a novel bilateral capsulotomy with focused ultrasound in refractory obsessive−compulsive disorder treatment. Mol. Psychiatry 30, 1897–1905 (2025).
Mantione, M., Nieman, D. H., Figee, M. & Denys, D. Cognitive-behavioural therapy augments the effects of deep brain stimulation in obsessive−compulsive disorder. Psychol. Med. 44, 3515–3522 (2014).
Graat, I. et al. Cyclic versus continuous deep brain stimulation in patients with obsessive compulsive disorder: a randomized controlled trial. Brain Stimul. 16, 82–87 (2023).
Rück, C., Larsson, J. K., Mataix-Cols, D. & Ljung, R. A register-based 13-year to 43-year follow-up of 70 patients with obsessive−compulsive disorder treated with capsulotomy. BMJ Open 7, e013133 (2017).
Kim, S. J. et al. A study of novel bilateral thermal capsulotomy with focused ultrasound for treatment-refractory obsessive–compulsive disorder: 2-year follow-up. J. Psychiatry Neurosci. 43, 327–337 (2018).
Tyagi, H. et al. A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive–compulsive disorder: clinical and imaging evidence for dissociable effects. Biol. Psychiatry 85, 726–734 (2019).
Copetti, M. E. et al. Obsessive−compulsive personality symptoms predict poorer response to gamma ventral capsulotomy for intractable OCD. Front. Psychiatry 10, 936 (2019).
Dell’Osso, B., Porta, M., Servello, D. & Altamura, A. C. Deep brain stimulation device removal after scar picking behaviors in a patient with treatment-resistant obsessive compulsive disorder. Brain Stimul. 6, 96–98 (2013).
Chang, C.-H., Chen, S.-Y., Tsai, S.-T. & Tsai, H.-C. Compulsive skin-picking behavior after deep brain stimulation in a patient with refractory obsessive–compulsive disorder. Medicine 96, e8012 (2017).
Nahas, Z. et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J. Clin. Psychiatry 66, 1097–1104 (2005).
Sabé, M. et al. Transcranial magnetic stimulation and transcranial direct current stimulation across mental disorders: a systematic review and dose-response meta-analysis. JAMA Netw. Open 7, e2412616 (2024).
Dannon, P. N. & Grunhaus, L. Effect of electroconvulsive therapy in repetitive transcranial magnetic stimulation non-responder MDD patients: a preliminary study. Int. J. Neuropsychopharmacol. 4, 265–268 (2001).
Yuan, S., Tirrell, E., Gobin, A. P. & Carpenter, L. L. Effect of previous electroconvulsive therapy on subsequent response to transcranial magnetic stimulation for major depressive disorder. Neuromodulation 23, 393–398 (2020).
Strandberg, P. et al. Electroconvulsive therapy versus repetitive transcranial magnetic stimulation in patients with a depressive episode: a register-based study. J. ECT 40, 88–95 (2024).
Kirov, G. et al. Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br. J. Psychiatry 193, 152–155 (2008).
Zhou, D. et al. Transcranial direct current stimulation combined with repetitive transcranial magnetic stimulation for depression: a randomized clinical trial. JAMA Netw. Open 7, e2444306 (2024).
Fitzgerald, P. B. et al. Accelerated repetitive transcranial magnetic stimulation in the treatment of depression. Neuropsychopharmacology 43, 1565–1572 (2018).
Chen, L. et al. Does switching between high frequency rTMS and theta burst stimulation improve depression outcomes? Brain Stimul. 15, 889–891 (2022).
Goodman, M. S. et al. Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy. Neuropsychopharmacology 50, 685–694 (2025).
Kar, S. K., Kumari, B., Joshi, M. & Singh, A. A case series on the effect of continuous theta burst stimulation over supplementary motor cortex in obsessive−compulsive disorder. Clin. Psychopharmacol. Neurosci. 23, 312–318 (2025).
Real, E. et al. Removing and reimplanting deep brain stimulation therapy devices in resistant OCD (when the patient does not respond): case report. BMC Psychiatry 16, 26 (2016).
Servello, D. et al. De novo and rescue DBS leads for refractory Tourette syndrome patients with severe comorbid OCD: a multiple case report. J. Neurol. 256, 1533–1539 (2009).
Basich-Pease, G. et al. Tractography-based DBS lead repositioning improves outcome in refractory OCD and depression. Front. Hum. Neurosci. 17, 1339340 (2023).
Richieri, R. et al. Positive clinical effects of gamma knife capsulotomy in a patient with deep brain stimulation-refractory Tourette syndrome and obsessive compulsive disorder. Clin. Neurol. Neurosurg. 170, 34–37 (2018).
Allam, A. K. et al. Effective deep brain stimulation for obsessive−compulsive disorder after failed anterior capsulotomy: illustrative cases. J. Neurosurg. Case Lessons 8, CASE24289 (2024).
Neimat, J. S. et al. Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am. J. Psychiatry 165, 687–693 (2008).
Chang, W. S., Roh, D., Kim, C.-H. & Chang, J. W. Combined bilateral anterior cingulotomy and ventral capsule/ventral striatum deep brain stimulation for refractory obsessive−compulsive disorder with major depression: do combined procedures have a long-term benefit? Restor. Neurol. Neurosci. 31, 723–732 (2013).
Kellner, CH. et al. Safety and efficacy of electroconvulsive therapy for depression in the presence of deep brain stimulation in obsessive−compulsive disorder. J. Clin. Psychiatry 77, 689–690 (2016).
Puigdemont, D. et al. Depressive relapse after initial response to subcallosal cingulate gyrus-deep brain stimulation in a patient with a treatment-resistant depression: electroconvulsive therapy as a feasible strategy. Biol. Psychiatry 66, e11–e12 (2009).
Volkaerts, L., Roels, R. & Bouckaert, F. Motor function improvement after electroconvulsive therapy in a parkinson’s disease patient with deep brain stimulator. J. ECT 36, 66–68 (2020).
Peroski, M. S., Chu, M. M., Doddi, S. R. & Regenold, W. T. The safety of electroconvulsive therapy in patients with implanted deep brain stimulators: a review of the literature and case report. J. ECT 35, 84–90 (2019).
Miron, J.-P., Desbeaumes Jodoin, V., Fournier-Gosselin, M.-P. & Lespérance, P. Safety of transcranial magnetic stimulation in an obsessive−compulsive disorder patient with deep brain stimulation: a case report. J. ECT 35, e7–e8 (2019).
D’Onofrio, V. et al. Combining transcranial magnetic stimulation and deep brain stimulation: current knowledge, relevance and future perspectives. Brain Sci. 13, 349 (2023).
Iannone, A., Allam, N. & Brasil-Neto, J. P. Safety of transcranial direct current stimulation in a patient with deep brain stimulation electrodes. Arq. Neuropsiquiatr. 77, 174–178 (2019).
Santermans, L., Vanderbruggen, N. & Baeken, C. Acute relapse after successful vagus nerve stimulation therapy: a case report of last-resort ECT treatment. Prim. Care Companion J. Clin. Psychiatry 12, PCC.09l00840 (2010).
Burke, M. J. & Husain, M. M. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression. J. ECT 22, 218–222 (2006).
Philip, N. S., Carpenter, S. L. & Carpenter, L. L. Safe use of repetitive transcranial magnetic stimulation in patients with implanted vagus nerve stimulators. Brain Stimul. 7, 608–612 (2014).
Conway, C. R., Gebretsadik, M. D. & Bucholz, R. D. Marked response to VNS in a post-cingulotomy patient: implications for the mechanism of action of VNS in TRD. CNS Spectr. 16, 135–141 (2011).
Mansour, L. T., Tomatis, V., Abdul Halim, A. & Knight, E. J. Electroconvulsive therapy in the presence of intracranial pathology: a literature review. J. ECT https://doi.org/10.1097/YCT.0000000000001209 (2025).
Noda, Y., Daskalakis, Z. J., Ramos, C. & Blumberger, D. M. Repetitive transcranial magnetic stimulation to maintain treatment response to electroconvulsive therapy in depression: a case series. Front. Psychiatry 4, 73 (2013).
Cristancho, M. A., Helmer, A., Connolly, R., Cristancho, P. & O’Reardon, J. P. Transcranial magnetic stimulation maintenance as a substitute for maintenance electroconvulsive therapy: a case series. J. ECT 29, 106–108 (2013).
Le, B. et al. A clinical case series of acute and maintenance home administered transcranial direct current stimulation in treatment-resistant depression. J. ECT 38, e11–e19 (2022).
Aaronson, S. T. et al. Vagus nerve stimulation in patients receiving maintenance therapy with electroconvulsive therapy: a series of 10 cases. J. ECT 37, 84–87 (2021).
Aboubakr, O. et al. Vagus nerve stimulation allows to cease maintenance electroconvulsive therapy in treatment-resistant depression: a retrospective monocentric case series. Front. Psychiatry 14, 1305603 (2023).
Bancel, T. et al. Sustained reduction of essential tremor with low-power non-thermal transcranial focused ultrasound stimulations in humans. Brain Stimul. 17, 636–647 (2024).
Rothärmel, M. et al. The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study. Psychol. Med. 53, 2060–2071 (2023).
Buday, J. et al. Seizure threshold manipulation in electroconvulsive therapy via repetitive transcranial magnetic stimulation. A novel way of augmentation? Brain Stimul. 13, 1631–1638 (2020).
Licht, C., Fuchs, S., Ruttmann, A., Richter, K. & Hillemacher, T. Repetitive transcranial magnetic stimulation (rTMS) for catatonia–a case report. Eur. Psychiatry 65, S740 (2022).
Szeska, C., Ventura-Bort, C., Giraudier, M. & Weymar, M. A vagal route to memory: evidence from invasive and non-invasive electrical vagus nerve stimulation studies and areas for future clinical application. Front. Hum. Neurosci. 19, 1595737 (2025).
Powers, M. B. et al. Vagus nerve stimulation therapy for treatment-resistant PTSD. Brain Stimul. 18, 665–675 (2025).
Gillving, C. et al. Seizure duration and electroconvulsive therapy in major depressive disorder. JAMA Netw. Open 7, e2422738 (2024).
Fox, M. D., Buckner, R. L., White, M. P., Greicius, M. D. & Pascual-Leone, A. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol. Psychiatry 72, 595–603 (2012).
Riva-Posse, P. et al. A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression. Mol. Psychiatry 23, 843–849 (2018).
Siddiqi, S. H. et al. Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease. Nat. Hum. Behav. 5, 1707–1716 (2021).
Runia, N. et al. Deep brain stimulation improves symptoms across all dimensions in treatment-resistant depression. Neurotherapeutics 22, e00623 (2025).
Alagapan, S. et al. Cingulate dynamics track depression recovery with deep brain stimulation. Nature 622, 130–138 (2023).
Drysdale, A. T. et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat. Med. 23, 28–38 (2017).
Solvason, H. B. et al. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes. Brain Stimul. 7, 219–225 (2014).
Rabin, J. S. et al. Commonly used outcome measures in neurosurgical trials for major depressive disorder might not capture clinically meaningful treatment effects. J. Neurol. Neurosurg. Psychiatry 93, 455–456 (2022).
Weigand, A. et al. Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites. Biol. Psychiatry 84, 28–37 (2018).
Elbau, I. G. et al. Functional connectivity mapping for rTMS target selection in depression. Am. J. Psychiatry 180, 230–240 (2023).
Scangos, K. W. et al. Closed-loop neuromodulation in an individual with treatment-resistant depression. Nat. Med. 27, 1696–1700 (2021).
Sheth, S. A., Rolston, J. D., Goodman, W. K. & Provenza, N. R. Is psychiatry ready for closed-loop invasive neuromodulation? JAMA Psychiatry 82, 1163–1164 (2025).
Brown, R. et al. Repetitive transcranial magnetic stimulation for post-traumatic stress disorder in adults. Cochrane Database Syst. Rev. 8, CD015040 (2024).
Parikh, T. K., Strawn, J. R., Walkup, J. T. & Croarkin, P. E. Repetitive transcranial magnetic stimulation for generalized anxiety disorder: a systematic literature review and meta-analysis. Int. J. Neuropsychopharmacol. 25, 144–146 (2022).
Wu, K. et al. Neuromodulation of eating disorders: a review of underlying neural network activity and neuromodulatory treatments. Brain Sci. 14, 200 (2024).
Kozel, F. A. et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J. Affect. Disord. 229, 506–514 (2018).
Mehta, D. D. et al. A systematic review and meta-analysis of neuromodulation therapies for substance use disorders. Neuropsychopharmacol. 49, 649–680 (2024).
Zangen, A. et al. Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial. World Psychiatry 20, 397–404 (2021).
Gazi, A. H. et al. Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: a double-blind, randomized, sham-controlled pilot study. Brain Stimul. 15, 1206–1214 (2022).
Klaming, R. et al. Noninvasive vagus nerve stimulation reduces withdrawal-related affective distress and improves functional outcomes in alcohol use disorder: a feasibility and acceptability pilot study. Neuromodulation 28, 1418–1428 (2025).
Li, J., Wang, J., Yang, Y., Gao, J. & Zhang, X. The effect of electroconvulsive and magnetic seizure therapy (MST) on cortical thickness in schizophrenia. CNS Neurosci. Ther. 31, e70309 (2025).
Stip, E., Blain-Juste, M.-E., Farmer, O., Fournier-Gosselin, M.-P. & Lespérance, P. Catatonia with schizophrenia: from ECT to rTMS. Encephale 44, 183–187 (2018).
Xu, D. et al. Maintenance repetitive transcranial magnetic stimulation (rTMS) weakly improved treatment effect in patients with treatment-resistant schizophrenia who responded to maintenance ECT and adjunct olanzapine treatment–a pilot study. Psychiatry Clin. Psychopharmacol. 30, 254–263 (2020).
Philip, N. S. et al. One year clinical outcomes after transcranial direct current stimulation and virtual reality for posttraumatic stress disorder. Brain Stimul. 17, 896–898 (2024).
Gurel, N. Z. et al. Transcutaneous cervical vagal nerve stimulation reduces sympathetic responses to stress in posttraumatic stress disorder: a double-blind, randomized, sham controlled trial. Neurobiol. Stress 13, 100264 (2020).
Hou, W. et al. Effect of transcranial direct current stimulation with concurrent cognitive performance targeting posterior parietal cortex vs prefrontal cortex on working memory in schizophrenia: a randomized clinical trial. Transl. Psychiatry 14, 279 (2024).
Cui, Y. et al. Efficacy and safety of transcutaneous auricular vagus nerve stimulation for patients with treatment-resistant schizophrenia with predominantly negative symptoms: a randomized clinical trial and efficacy sensitivity biomarkers. Mol. Psychiatry 30, 5437–5447 (2025).
Rezai, A. et al. Focused ultrasound neuromodulation: exploring a novel treatment for severe opioid use disorder. Biol. Psychiatry 98, 56–64 (2025).
Zhai, Z. et al. The efficacy of low-intensity transcranial ultrasound stimulation on negative symptoms in schizophrenia: a double-blind, randomized sham-controlled study. Brain Stimul. 16, 790–792 (2023).
Mahdavi, K. D. et al. A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorder. J. Psychiatr. Res. 168, 125–132 (2023).
Mahoney, J. J. et al. Low-intensity focused ultrasound targeting the nucleus accumbens as a potential treatment for substance use disorder: safety and feasibility clinical trial. Front. Psychiatry 14, 1211566 (2023).
Koek, R. J. et al. Deep brain stimulation of the amygdala for treatment-resistant combat post-traumatic stress disorder: long-term results. J. Psychiatr. Res. 175, 131–139 (2024).
Bach, P. et al. Deep brain stimulation of the nucleus accumbens in treatment-resistant alcohol use disorder: a double-blind randomized controlled multi-center trial. Transl. Psychiatry 13, 49 (2023).
Davidson, B. et al. Deep brain stimulation of the nucleus accumbens in the treatment of severe alcohol use disorder: a phase I pilot trial. Mol. Psychiatry 27, 3992–4000 (2022).
Rezai, A. R. et al. Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorder. J. Neurosurg. 140, 231–239 (2024).
Ge, S. et al. Effects of deep brain stimulation of the nucleus accumbens and anterior limb of the internal capsule on heroin addiction: over five years of long-term follow-up in a prospective open-label pilot study. Transl. Psychiatry 15, 415 (2025).
Lipsman, N. et al. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. Lancet Psychiatry 4, 285–294 (2017).
Lin, Z., Dai, L., Zhang, C., Li, D. & Sun, B. Rescue anterior capsulotomy after failure of nucleus accumbens deep brain stimulation in anorexia nervosa: a case report. Stereotact. Funct. Neurosurg. 99, 491–495 (2021).
Zhu, R. et al. Deep brain stimulation of nucleus accumbens with anterior capsulotomy for drug addiction: a case report. Stereotact. Funct. Neurosurg. 98, 345–349 (2020).
来源:Nature 健康护理主题 · nature.com